17.12.2022 - Chair of the Board of Directors, Sean P. Nolan, appointed Chief Executive Officer Board Director, Sukumar Nagendran, M.D., appointed President and Head of R&D DALLAS, Dec. 16, 2022 (GLOBE NEWSWIRE) - Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a . Seite 1
Chair of the Board of Directors, Sean P. Nolan, appointed Chief Executive Officer Board Director, Sukumar Nagendran, M.D., appointed President and Head of.
06.07.2022 - President, Founder and Chief Executive Officer to participate in “AAV Gene Therapy: Delivery and Beyond” panel discussion on Wednesday, July 13, 2022 at 10:00 am ETDALLAS, July 06, 2022 (GLOBE NEWSWIRE) - Taysha Gene Therapies, Inc. (Nasdaq: .